Protection against amyloid beta cytotoxicity by sulforaphane: Role of the proteasome.
 

Posts


Write a Post
02-03-09 08:40 AM
Anonymous
Protection against amyloid beta cytotoxicity by sulforaphane: Role of the proteasome.
Reply
Related Articles

Protection against amyloid beta cytotoxicity by sulforaphane: Role of the proteasome.

Arch Pharm Res. 2009 Jan;32(1):109-15

Authors: Park HM, Kim JA, Kwak MK

The 26S proteasome plays a major role in degradation of abnormal proteins within the cell. The indirect antioxidant including sulforaphane (SFN) protects cells from oxidative damage by increasing the expression of Nrf2-target genes. It has been observed that the expression of multiple subunits of the proteasome was up-regulated by indirect antioxidants through the Nrf2 pathway. In the current study, the role of SFN in amyloid beta(1-42) (Abeta(1-42))-induced cytotoxicity has been investigated in murine neuroblastoma cells. Treatment with SFN protected cells from Abeta(1-42)-mediated cell death in Neuro2A and N1E 115 cells. Inhibition of proteasome activities by MG132 could abolish the protective effect of SFN against Abeta(1-42). Neuro2A cells, which were stably overexpressing the catalytic subunit of the proteasome PSMB5, showed an elevated resistance toward Abeta(1-42) toxicity compared to control cells. Furthermore, the in vitro assay demonstrated that the Abeta(1-42) peptide is degraded by the proteasome fraction. These results suggest that proteasome-inducing indirect antioxidants may facilitate the removal of the Abeta(1-42) peptide and lead to the amelioration of abnormal protein-associated etiologies.

PMID: 19183883 [PubMed - in process]